IL1B and cancer: In this setting, cancer-derived exosomes may trigger distinct intracellular signaling pathways in receptor cells, culminating in NF-κB activation and the subsequent expression of the IL-1β gene or the activation of inflammasomes through NLRP3 for the cleavage of pro-IL-1β into its active form (190, 191).